37
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Upon detection of pathogen-associated molecular patterns, innate immune receptors initiate inflammatory responses. These receptors include cytoplasmic NOD-like receptors (NLRs), whose stimulation recruits and proteolytically activates caspase-1 within the inflammasome, a multi-protein complex. Caspase-1 mediates the production of interleukin-1 family cytokines (IL1FCs), leading to fever, and inflammatory cell death (pyroptosis) 1, 2 . Mutations that constitutively activate these pathways underlie several autoinflammatory diseases with diverse clinical features 3 . We describe a family with a previously unreported syndrome featuring neonatal-onset enterocolitis, periodic fever, and fatal/near-fatal episodes of autoinflammation caused by a de novo gain-of-function mutation (p.V341A) in the HD1 domain of NLRC4 that co-segregates with disease. Mutant NLRC4 causes constitutive Interleukin-1 family cytokine production and macrophage cell death. Infected patient macrophages are polarized toward pyroptosis and exhibit abnormal staining for inflammasome components. These findings describe and reveal the cause of a life-threatening but treatable autoinflammatory disease that underscores the divergent roles of the NLRC4 inflammasome.

          Related collections

          Most cited references11

          • Record: found
          • Abstract: found
          • Article: not found

          A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes.

          Interleukin-1 beta (IL-1 beta)-converting enzyme cleaves the IL-1 beta precursor to mature IL-1 beta, an important mediator of inflammation. The identification of the enzyme as a unique cysteine protease and the design of potent peptide aldehyde inhibitors are described. Purification and cloning of the complementary DNA indicates that IL-1 beta-converting enzyme is composed of two nonidentical subunits that are derived from a single proenzyme, possibly by autoproteolysis. Selective inhibition of the enzyme in human blood monocytes blocks production of mature IL-1 beta, indicating that it is a potential therapeutic target.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The Protein Data Bank. A computer-based archival file for macromolecular structures.

            The Protein Data Bank is a computer-based archival file for macromolecular structures. The Bank stores in a uniform format atomic co-ordinates and partial bond connectivities, as derived from crystallographic studies. Text included in each data entry gives pertinent information for the structure at hand (e.g. species from which the molecule has been obtained, resolution of diffraction data, literature citations and specifications of secondary structure). In addition to atomic co-ordinates and connectivities, the Protein Data Bank stores structure factors and phases, although these latter data are not placed in any uniform format. Input of data to the Bank and general maintenance functions are carried out at Brookhaven National Laboratory. All data stored in the Bank are available on magnetic tape for public distribution, from Brookhaven (to laboratories in the Americas), Tokyo (Japan), and Cambridge (Europe and worldwide). A master file is maintained at Brookhaven and duplicate copies are stored in Cambridge and Tokyo. In the future, it is hoped to expand the scope of the Protein Data Bank to make available co-ordinates for standard structural types (e.g. alpha-helix, RNA double-stranded helix) and representative computer programs of utility in the study and interpretation of macromolecular structures.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf.

              Macrophages respond to Salmonella typhimurium infection via Ipaf, a NACHT-leucine-rich repeat family member that activates caspase-1 and secretion of interleukin 1beta. However, the specific microbial salmonella-derived agonist responsible for activating Ipaf is unknown. We show here that cytosolic bacterial flagellin activated caspase-1 through Ipaf but was independent of Toll-like receptor 5, a known flagellin sensor. Stimulation of the Ipaf pathway in macrophages after infection required a functional salmonella pathogenicity island 1 type III secretion system but not the flagellar type III secretion system; furthermore, Ipaf activation could be recapitulated by the introduction of purified flagellin directly into the cytoplasm. These observations raise the possibility that the salmonella pathogenicity island 1 type III secretion system cannot completely exclude 'promiscuous' secretion of flagellin and that the host capitalizes on this 'error' by activating a potent host-defense pathway.
                Bookmark

                Author and article information

                Journal
                9216904
                2419
                Nat Genet
                Nat. Genet.
                Nature genetics
                1061-4036
                1546-1718
                29 July 2014
                14 September 2014
                October 2014
                01 April 2015
                : 46
                : 10
                : 1135-1139
                Affiliations
                [1 ]Department of Pediatrics, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06510, USA
                [2 ]Department of Internal Medicine, Yale University School of Medicine, 330 Cedar Street, New Haven, Connecticut 06510, USA
                [3 ]Department of Genetics, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06510, USA
                [4 ]Howard Hughes Medical Institute, Yale University School of Medicine, 295 Congress Avenue, New Haven, Connecticut 06510, USA
                [5 ]Department of Pharmacology, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06510, USA
                [6 ]Department of Immunobiology, Yale University School of Medicine, 300 Cedar Street, New Haven, Connecticut 06510, USA
                [7 ]Department of Pathology, Yale University School of Medicine, 310 Cedar Street, New Haven, Connecticut 06510, USA
                [8 ]Department of Microbial Pathogenesis, Yale University School of Medicine, 295 Congress Ave, New Haven, Connecticut 06520, USA
                Author notes
                [** ]These authors jointly directed this work. Correspondence should be addressed to R.P.L. ( richard.lifton@ 123456yale.edu ), or B.I.K. ( barbara.kazmierczak@ 123456yale.edu ).
                Article
                NIHMS616064
                10.1038/ng.3066
                4177367
                25217960
                71792c4f-b54e-450c-b127-76cf3aae5ff8
                History
                Categories
                Article

                Genetics
                Genetics

                Comments

                Comment on this article